Fatigable ptosis as an initial presentation of adult-onset Leigh syndrome.

Neurology

From the Departments of Neurology (E.H.O., S.-H.C., J.-W.C., J.-H.C.) and Radiology (S.K.B.), Research Institute for Convergence of Biomedical Science and Technology, Pusan National University School of Medicine, Pusan National University Yangsan Hospital; and Department of Neurology (S.-Y.C., K.-D.C.), Pusan National University School of Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, South Korea.

Published: October 2017

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000004528DOI Listing

Publication Analysis

Top Keywords

fatigable ptosis
4
ptosis initial
4
initial presentation
4
presentation adult-onset
4
adult-onset leigh
4
leigh syndrome
4
fatigable
1
initial
1
presentation
1
adult-onset
1

Similar Publications

Ptosis in human immunodeficiency virus-infected patients under long-term antiretroviral treatment.

Clin Neurol Neurosurg

December 2024

Department of Neurosciences and Mental Health, Unidade Local de Saúde de Santa Maria, Lisbon, Portugal; Faculdade de Medicina-Instituto de Medicina Molecular, Centro de Estudos Egas Moniz, Universidade de Lisboa, Lisbon, Portugal.

Objective: To present cases of ptosis in HIV-1 patients on long-term antiretroviral therapy (ART) and review the existing literature.

Methods: Five HIV-1-positive patients with slowly progressive bilateral ptosis underwent a comprehensive diagnostic evaluation, including imaging studies, neurophysiological testing, muscle biopsy, and genetic analysis. A literature review was conducted.

View Article and Find Full Text PDF

CHRNE-related congenital myasthenic syndrome in Iran: Clinical and molecular insights.

Neuromuscul Disord

October 2024

Neuromuscular Research Center, Tehran University of Medical Sciences, Tehran, Iran; Department of Neurology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran. Electronic address:

Variants in the CHRNE gene can lead to a condition called congenital myasthenic syndrome (CMS), which affects the neuromuscular junction (NMJ). CHRNE mutations are the most common cause of CMS. Seventy-seven patients with a possible diagnosis of CMS were referred to the neuromuscular clinic of Shariati Hospital affiliated with the Tehran University of Medical Sciences.

View Article and Find Full Text PDF
Article Synopsis
  • The study assessed the link between inherited mitochondrial dysfunction and neuromuscular junction (NMJ) remodeling in patients with mitochondrial disorders, analyzing muscle biopsies from 15 patients and 10 controls.
  • Results showed that patients with mitochondrial disorders had significantly more remodeled and neoformed NMJ endplates, with a trend towards increased Schwann cell extensions, indicating NMJ alterations even without muscle weakness.
  • The findings suggest that mitochondrial disorders may lead to NMJ remodeling as a primary issue, separate from structural muscle damage, though the exact mechanisms and clinical indicators warrant further investigation.
View Article and Find Full Text PDF

Loss-of-function variants in cause congenital myopathy with prominent facial and ocular involvement.

J Med Genet

September 2024

The John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

Article Synopsis
  • This study looked at four people with a muscle disease that affects their faces, eyes, and ability to move.
  • The researchers found that all four had similar symptoms and looked at their DNA to understand the problem.
  • They discovered that a gene called junctophilin-1 doesn't work properly in these patients, which is important for muscle function, and this could explain their muscle weakness and other symptoms.
View Article and Find Full Text PDF
Article Synopsis
  • Congenital Myasthenic Syndromes (CMS) are rare genetic disorders that result in muscle weakness due to problems with neuromuscular transmission, particularly caused by issues in acetylcholine synthesis, leading to life-threatening breathing problems.
  • Two male patients diagnosed with CHT1-CMS exhibited symptoms like apnea, weakness, and developmental delays; treatment with pyridostigmine only partially helped their condition.
  • This report highlights the serious impacts of CMS associated with the SLC5A7 gene mutations, particularly with episodes of apnea and potential central nervous system complications, and notes a lack of documented cases in Latin America.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!